Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2026-01-17 @ 1:51 AM
Study NCT ID:
NCT03387020
Status:
COMPLETED
Last Update Posted:
2021-08-27
First Post:
2017-12-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors
Sponsor:
Pediatric Brain Tumor Consortium
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent Childhood Ependymoma | View |
| None | Recurrent Diffuse Intrinsic Pontine Glioma | View |
| None | Recurrent Medulloblastoma | View |
| None | Refractory Diffuse Intrinsic Pontine Glioma | View |
| None | CNS Embryonal Tumor, Not Otherwise Specified | View |
| None | Malignant Glioma | View |
| None | Recurrent Atypical Teratoid/Rhabdoid Tumor | View |
Keywords: